Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire
Acta Otorhinolaryngologica Italica · 2025
DOI: 10.14639/0392-100x-a1077 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Otorhinolaryngologica Italica, 2025. Verfasst von Pietro De Luca und 22 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology Department, Isola Tiberina-Gemelli Isola Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Laryngectomy, Laryngeal Neoplasms, Deglutition, Deglutition Disorders. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To report the data obtained by translating the Swallowing Outcomes After Laryngectomy (SOAL) questionnaire in Italian to validate it and offer a valid tool for Italian-speaking patients and clinicians.
Methods
A multicentre case-control study was performed between January 1st 2024 and October 1st 2024. In all, 494 patients consecutively treated for laryngeal squamous cell carcinoma were included in the study (group 1). Healthy controls and patients who underwent radiotherapy (group 2) or chemotherapy (group 3) of the head and neck district were the two control groups.
Results
Statistically significant differences were observed comparing SOAL scores among the three groups (ANOVA: p < 0.0001); significant differences were observed between group 1 (mean 0.89 +/- 1.31; 95% CI: 0-3) and group 2 (mean 6.78 +/- 4.59; 95% CI: 1-24) (Bonferroni-Holmes [BH] p < 0.01), and group 1 and group 3 (mean 11 +/- 7.47; 95% CI: 0-38) (BH: p 0 < 0.01). Statistically significant differences in the SOAL scores were also identified between group 2 and 3 (BH: p < 0.01).
Conclusions
The SOAL questionnaire may be a useful tool to correctly understand patients' concerns for swallowing to promptly and rapidly manage them and improve patient's quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Otolaryngology Department, Isola Tiberina-Gemelli Isola Hospital, Rome, Italy.
- ENT Unit-Department of Mental, Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Department Otolaryngology - Head and Neck Surgery, IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
- Otolaryngology Department, University of Bologna, Bologna, Italy.
- Department of Otorhinolaryngology-Head and Neck Surgery, Hospital of Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
- Head and Neck Department, ENT Clinic, University of Trieste, Trieste, Italy.
Zitieren
APA
De Luca, P., Di Stadio, A., Petruzzi, G., Fermi, M., Gazzini, L., Marcuzzo, A. V., Gardenal, N., Aragona, T., Atturo, F., de Campora, L., Scarpa, A., Avallone, E., Caselli, A., Olive, M., Salzano, F. A., Tirelli, G., Molteni, G., Cassano, L., Calabrese, L., …, & Camaioni, A. (2025). Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire. Acta Otorhinolaryngologica Italica. https://doi.org/10.14639/0392-100x-a1077
Vancouver
De Luca P, Di Stadio A, Petruzzi G, Fermi M, Gazzini L, Marcuzzo AV, et al. Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire. Acta Otorhinolaryngologica Italica. 2025. doi:10.14639/0392-100x-a1077
BibTeX
@article{DeLuca2025,
author = {De Luca, Pietro and Di Stadio, Arianna and Petruzzi, Gerardo and Fermi, Matteo and Gazzini, Luca and Marcuzzo, Alberto Vito and Gardenal, Nicoletta and Aragona, Teodoro and Atturo, Francesca and de Campora, Luca and Scarpa, Alfonso and Avallone, Emilio and Caselli, Arianna and Olive, Maria and Salzano, Francesco Antonio and Tirelli, Giancarlo and Molteni, Gabriele and Cassano, Lazzaro and Calabrese, Luca and Pellini, Raul and Presutti, Livio and Radici, Marco and Camaioni, Angelo},
title = {Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire},
journal = {Acta Otorhinolaryngologica Italica},
year = {2025},
doi = {10.14639/0392-100x-a1077}
}
EUVIMED